# Corcept Therapeutics Inc: Form 8-K, filed Feb 15, 2024

- Company: [Corcept Therapeutics Inc](/companies/cort.md) (CIK 1088856)
- Form: 8-K
- Filed: 2024-02-15
- Accepted by EDGAR: Feb 15, 2024, 16:11 ET
- Period: 2024-02-15
- Accession: 0001628280-24-005048
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1088856/000162828024005048/cort-20240215.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1088856/000162828024005048/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1088856/000162828024005048/cort-20240215.htm

Filed Feb 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-005048. Last ingested by Listed: Nov 3, 2026, 19:15 ET. No prices; not investment advice.